Template:Bleeding: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
 
(5 intermediate revisions by one other user not shown)
Line 29: Line 29:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Bleeding Academic Research Consortium]]
: [[Bleeding Academic Research Consortium]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[TIMI bleeding criteria]]
: [[TIMI bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[GUSTO bleeding criteria]]
: [[GUSTO bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[CURE bleeding criteria]]
: [[CURE bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[ACUITY HORIZONS bleeding criteria]]
: [[ACUITY HORIZONS bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[STEEPLE bleeding criteria]]
: [[STEEPLE bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[PLATO bleeding criteria]]
: [[PLATO bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[GRACE bleeding criteria]]
: [[GRACE bleeding criteria]]
|-  
|-  
!
!
Line 82: Line 82:
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Line 95: Line 94:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Perioperative bleeding coagulation monitoring|Coagulation Monitoring]]
: [[Bleeding perioperative bleeding anemia management|Anemia Management]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Perioperative bleeding anemia management|Anemia Management]]
: [[Bleeding perioperative bleeding monitoring of coagulation status and platelet function|Coagulation Monitoring]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Perioperative bleeding coagulation management|Coagulation Management]]
: [[Bleeding perioperative bleeding coagulation management|Coagulation Management]]
|-
|-
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]]
: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Antiplatelet Agents|Antiplatelet Agents]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Heparin|Heparin]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Fondaparinux|Fondaparinux]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Vitamin K Antagonists|Vitamin K Antagonists]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#New Oral Anticoagulants|New Oral Anticoagulants]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Comorbidities Involving Hemostatic Derangement|Comorbidities Involving Hemostatic Derangement]]
|-
|-
!
!

Latest revision as of 13:10, 25 April 2014